European Journal of Pharmacology

European Journal of Pharmacology is a peer-reviewed scientific journal that publishes research articles in the field of pharmacology. Established in 1967, it has grown to become one of the leading journals in the pharmacological sciences, offering a platform for the dissemination of important experimental and clinical research related to drugs and drug action.

Overview

The European Journal of Pharmacology covers a broad spectrum of topics within pharmacology, including molecular pharmacology, neuropharmacology, cardiovascular pharmacology, immunopharmacology, and pulmonary pharmacology. The journal aims to provide a comprehensive understanding of drug action at the cellular, molecular, and behavioral levels. It publishes original research articles, reviews, and short communications that contribute significantly to the advancement of the pharmacological sciences.

Publication Details

The journal is published by Elsevier, one of the world's leading publishers of scientific, technical, and medical information. It is available both in print and online, with articles accessible through Elsevier's ScienceDirect platform. The European Journal of Pharmacology operates under a subscription model, with options for institutions and individuals to access content.

Editorial Board

The editorial board of the European Journal of Pharmacology consists of distinguished scientists and researchers from around the world. These members are responsible for maintaining the journal's high standards of scientific quality and integrity. The board oversees the peer-review process, ensuring that all published articles meet the rigorous criteria of relevance, originality, and scientific excellence.

Impact Factor

The European Journal of Pharmacology has a notable impact factor, which is a measure of the frequency with which the average article in a journal has been cited in a particular year. This metric is often used as an indicator of the journal's prestige and the significance of its published research.

Submission and Peer Review

Authors wishing to submit their work to the European Journal of Pharmacology must adhere to the journal's submission guidelines, which detail the manuscript preparation, formatting, and submission process. The journal employs a double-blind peer review process, where both the reviewers and the authors remain anonymous to each other, ensuring an unbiased evaluation of the manuscripts.

Research Areas

The journal welcomes submissions across a wide range of research areas within pharmacology, including but not limited to:

• Molecular pharmacology: Studies on the molecular mechanisms of drug action and the interaction of drugs with cellular components.
• Neuropharmacology: Research on the effects of drugs on the nervous system and the potential treatment of neurological disorders.
• Cardiovascular pharmacology: Investigations into drugs affecting the heart and blood vessels, with implications for treating cardiovascular diseases.
• Immunopharmacology: Studies on the impact of drugs on the immune system, including drug-induced immunomodulation.
• Pulmonary pharmacology: Research on pharmacological interventions for respiratory diseases and conditions.

Conclusion

The European Journal of Pharmacology continues to play a pivotal role in the dissemination of high-quality research in pharmacology. Its comprehensive coverage of the field, combined with a rigorous peer-review process, ensures that the journal remains a key resource for researchers, clinicians, and students interested in the latest developments in drug research and pharmacological science.

   This article is a  stub. You can help WikiMD by expanding it!